Portfolio company
Tetraneuron
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops gene therapies to treat Alzheimer's and other neurodegenerative diseases for healthcare providers and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NeurOdys Therapeutics
This biotechnology company develops small molecule therapies for neurodegenerative disorders including Alzheimer's and Parkinson's diseases for healthcare providers and patients.
Neuromedical
This company develops non-invasive neuromodulation devices to treat cognitive impairments and Alzheimer's disease for healthcare professionals and patients.
Cajal Neuroscience
This biotechnology company develops drug discovery platforms and therapeutics for neurodegenerative diseases to assist healthcare providers and patients.
Muna Therapeutics
This biopharmaceutical company develops small-molecule therapeutics to treat neurodegenerative diseases, such as Alzheimer's and Parkinson's, for patients and healthcare providers.
Tetra Therapeutics
This biotechnology company develops therapeutic drugs for patients suffering from neurological conditions such as Alzheimer's disease and Fragile X syndrome.
Nuuron
This neurotech company develops a digital neuromodulation therapy delivered through virtual reality headsets to treat patients with Alzheimer's disease.
Kalgene
This biotechnology company develops precision medicine therapeutics and companion diagnostics to treat Alzheimer's disease and various cancers for patients and clinical providers.
Cerevance
This pharmaceutical company develops therapies for neurodegenerative diseases and central nervous system disorders for patients and healthcare providers.
